The North America capsule endoscopes market size is expected to reach US$ 534.04 million by 2031 from US$ 335.33 million in 2024. The market is estimated to record a CAGR of 7.0% from 2025 to 2031.
Executive Summary and North America Capsule Endoscopes Market Analysis:
The capsule endoscopes market in North America is mature and thrives on innovation, with broad use in outpatient and specialty care. The region's focus on early detection and patient comfort has turned capsule endoscopy into a go-to tool for gut diagnostics. The U.S. leads the region supported by strong reimbursement policies clinical studies, and its inclusion in routine screening programs. Private health networks and academic hospitals play a big role in driving adoption. The market grows due to ongoing product improvements such as AI-boosted imaging and remote monitoring features. While Canada and Mexico are expanding access, the U.S. stays ahead in both volume and tech advances. Rising awareness about colon cancer and small bowel issues keeps pushing demand up. As health systems put more weight on non-invasive tests capsule endoscopy stays at the heart of North America's gut care approach.
North America Capsule Endoscopes Market Strategic Insights
Key segments that contributed to the derivation of the capsule endoscopes market analysis are product type, application, and end user.
- By product type, the capsule endoscopes market is segmented into small bowel capsule and colon capsule. The small bowel capsule segment dominated the market in 2024.
- By application, the capsule endoscopes market is segmented into obscure gastrointestinal bleeding, Crohn's disease, tumors, celiac disease, and others. The obscure gastrointestinal bleeding segment dominated the market in 2024.
- By end user, the market is segmented into hospitals, specialty clinics, diagnostic centers, and others. The hospitals segment held the largest share of the market in 2024.
North America Capsule Endoscopes Market Outlook
The capsule endoscope market in North America is robust as a result of its advanced healthcare systems and the emphasis on preventive medicine. Capsule endoscopy is the doctor’s initial preference for diagnosing GI bleeding, Crohn’s disease, and colorectal cancer. The country’s comprehensive insurance coverage and medical guidelines support non-invasive screening with capsule endoscopy. Healthcare providers in the United States have embedded capsule endoscopy into their outpatient clinics as part of their normal diagnostic process. Healthcare providers appreciate that the non-invasive screening of capsule endoscopy reduces procedure time, and the potential for improved patient adherence to process makes it appealing. The growth of remote diagnostics and explosion of digital health applications creates further growth opportunities. There is also significant interest surrounding AI-based capsule analysis in hospitals and medical research centers to maximize accuracy and optimize workflow. With the growing awareness of GI health, education for patients, and screening programs, capsule endoscopy maintains popularity as a regular diagnostic tool throughout North America.
North America Capsule Endoscopes Market Country Insights
Based on country, the North America capsule endoscopes market is segmented into the United States, Canada and Mexico. The United States held the largest share in 2024.
The United States represents the largest market for capsule endoscopes in North America, fueled by advanced health care infrastructure, high patient demand, and a shift to more minimally invasive surgeries. Hospitals and outpatient surgery centers in major urban areas have state-of-the-art operating rooms that routinely use a capsule endoscope in diagnosis of diseases such as colorectal cancer, GI bleeding and others. Private hospital networks and academic medical center systems work together with top global device companies to procure the latest generation endoscopic equipment, maintenance, and training support. Government-funded and privately funded insurance payments are also encouraging adoption of minimally invasive surgery, which increases the demand for high-quality capsule endoscope devices. The U.S. also has established professional training programs for surgeons and technicians to properly use and care for devices. Although cost and regulations continue to be limiting factors, the U.S. advanced health care system, surgical capabilities, and willingness to invest in new technologies create a strong growth driver for capsule endoscopes in North America.
North America Capsule Endoscopes Market Report Highlights
| Report Attribute | Details |
| Market size in 2024 | US$ 335.33 Million |
| Market Size by 2031 | US$ 534.04 Million |
| CAGR (2025 - 2031) | 7.0% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Product Type
|
|
Regions and Countries Covered
|
|
| North America | US, Canada, Mexico |
| Market leaders and key company profiles |
|
North America Capsule Endoscopes Market Company Profiles
Medtronic, Olympus Corporation, CapsoVision, Inc., BioCam, Shangxian Minimal Invasive Inc., AnX Robotics, JINSHAN Science & Technology and RF Co., Ltd. are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.
North America Capsule Endoscopes Market Research Methodology:
The following methodology has been followed for the collection and analysis of data presented in this report:
-
Secondary Research
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
- Company websites, annual reports, financial statements, broker analyses, and investor presentations
- Industry trade journals and other relevant publications
- Government documents, statistical databases, and market reports
- News articles, press releases, and webcasts specific to companies operating in the market
Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.
-
Primary Research
Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:
- Refine findings from secondary research
- Enhance the expertise and market understanding of the analysis team
- Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects
Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:
- Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
- External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
North America Capsule Endoscopes Market Country and Regional Insights
North America Capsule Endoscopes Key Sources Referred:
- The World Bank
- World Health Organization (WHO)
- Center for Disease Control and Prevention (CDC)
- American Society for Gastrointestinal Endoscopy
- European Society of Gastrointestinal Endoscopy
- World Endoscopy Organization
- Society of American Gastrointestinal and Endoscopic Surgeons
- Global Cancer Observatory
- Company website
- Company annual reports
- Company investor presentations
